SCHEMBL2004869

SCHEMBL2004869

CCCC=CCCCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.39
LMNA P02545 1/20 0.38
FAAH O00519 3/20 0.36
TRPV1 Q8NER1 1/20 0.36
HIF1A Q16665 2/20 0.34
EPAS1 Q99814 2/20 0.34
CETP P11597 1/20 0.34
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004867 1.00 CNR1 (0.39) CNR1LMNAFAAHTRPV1HIF1A
SCHEMBL2001832 0.92 LMNA (0.42) CNR1LMNAFAAHTRPV1HIF1A
SCHEMBL2001830 0.92 LMNA (0.42) CNR1LMNAFAAHTRPV1HIF1A
SCHEMBL30629413 0.90 FAAH (0.43) CNR1LMNAFAAHTRPV1HIF1A
SCHEMBL2000652 0.90 CNR1 (0.42) CNR1LMNAFAAHTRPV1CETP
SCHEMBL2000655 0.90 CNR1 (0.42) CNR1LMNAFAAHTRPV1CETP
SCHEMBL11973140 0.87 FAAH (0.50) CNR1LMNAFAAHTRPV1
SCHEMBL11973144 0.87 FAAH (0.50) CNR1LMNAFAAHTRPV1
SCHEMBL4224710 0.85 FAAH (0.54) CNR1LMNAFAAHTRPV1
SCHEMBL23229756 0.84 ALDH1A1 (0.39) CNR1LMNAHIF1AEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102827269-B Thymulin alpha 1 analog and preparation method thereof 中肽生化有限公司 2017-04-12 CN disclosed
US-20120208959-A1 METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2012-08-16 US disclosed
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION Univ. of Southern Mississippi Res. Foundation (US) 2012-06-14 US disclosed
US-7960477-B2 Polyamides with acrylate rubbers BASF SE (DE) 2011-06-14 US disclosed
US-7816441-B2 Dispersing assistant for emulsion and suspension polymerization BASF SE (DE) 2010-10-19 US disclosed
US-20100249325-A1 POLYMER POWDER WITH HIGH RUBBER CONTENT AND PRODUCTION THEREOF BASF SE (DE) 2010-09-30 US disclosed
US-20100234506-A1 AQUEOUS BINDER FOR FIBROUS OR GRANULAR SUBSTRATES BASF SE (DE) 2010-09-16 US disclosed
US-20100174025-A1 N-BA-ALKENE COPOLYMERS AS GRAFT BASE FOR ABS POLYMERS BASF SE (DE) 2010-07-08 US disclosed
US-20100152380-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2010-06-17 US disclosed
US-20100093905-A1 AQUEOUS BINDER FOR GRANULAR AND/OR FIBROUS SUBSTRATES BASF SE (DE) 2010-04-15 US disclosed
US-20100069597-A1 FINE-PARTICLED POLYMER DISPERSIONS CONTAINING STARCH BASF SE (DE) 2010-03-18 US disclosed
US-20100048821-A1 POLYAMIDES WITH ACRYLATE RUBBERS BASF SE (DE) 2010-02-25 US disclosed
US-20100022708-A1 DISPERSING ASSISTANT FOR EMULSION AND SUSPENSION POLYMERIZATION BASF SE (DE) 2010-01-28 US disclosed
US-20090275681-A1 PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2009-11-05 US disclosed
CN-101558119-A Polyamide containing acrylate rubber BASF SE (DE) 2009-10-14 CN disclosed
US-20080221267-A1 Process for Preparing an Aqueous Addition-Polymer Dispersion BASF AKTIENGESELLSCHAFT (DE) 2008-09-11 US disclosed
CN-1046529-A Carbostyril derivative OTSUKA PHARMA CO LTD (JP) 1990-10-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149840-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION PUF60, PARG, ACMSD CNR1 1709/4885LMNA 2901/4885FAAH 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.